TY - JOUR
T1 - Group therapy on in utero colonization
T2 - seeking common truths and a way forward
AU - Silverstein, Rachel B.
AU - Mysorekar, Indira U.
N1 - Funding Information:
This work was funded in part by a grant from the National Institutes for Health/National Institute for Child Health and Development R01HD091218 to IUM. R.B.S. was supported by a MARC uSTAR fellowship.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - The human microbiome refers to the genetic composition of microorganisms in a particular location in the human body. Emerging evidence over the past many years suggests that the microbiome constitute drivers of human fate almost at par with our genome and epigenome. It is now well accepted after decades of disbelief that a broad understanding of human development, health, physiology, and disease requires understanding of the microbiome along with the genome and epigenome. We are learning daily of the interdependent relationships between microbiome/microbiota and immune responses, mood, cancer progression, response to therapies, aging, obesity, antibiotic usage, and overusage and much more. The next frontier in microbiome field is understanding when does this influence begin? Does the human microbiome initiate at the time of birth or are developing human fetuses already primed with microbes and their products in utero. In this commentary, we reflect on evidence gathered thus far on this question and identify the unknown common truths. We present a way forward to continue understanding our microbial colleagues and our interwoven fates.
AB - The human microbiome refers to the genetic composition of microorganisms in a particular location in the human body. Emerging evidence over the past many years suggests that the microbiome constitute drivers of human fate almost at par with our genome and epigenome. It is now well accepted after decades of disbelief that a broad understanding of human development, health, physiology, and disease requires understanding of the microbiome along with the genome and epigenome. We are learning daily of the interdependent relationships between microbiome/microbiota and immune responses, mood, cancer progression, response to therapies, aging, obesity, antibiotic usage, and overusage and much more. The next frontier in microbiome field is understanding when does this influence begin? Does the human microbiome initiate at the time of birth or are developing human fetuses already primed with microbes and their products in utero. In this commentary, we reflect on evidence gathered thus far on this question and identify the unknown common truths. We present a way forward to continue understanding our microbial colleagues and our interwoven fates.
KW - Decidua
KW - Extravillous trophoblasts
KW - Kitome
KW - Low biomass microbial communities
KW - Microbiome
KW - Micrococcus
KW - Placenta
KW - Pregnancy
KW - Ralstonia
UR - http://www.scopus.com/inward/record.url?scp=85099238900&partnerID=8YFLogxK
U2 - 10.1186/s40168-020-00968-w
DO - 10.1186/s40168-020-00968-w
M3 - Comment/debate
C2 - 33436100
AN - SCOPUS:85099238900
VL - 9
JO - Microbiome
JF - Microbiome
IS - 1
M1 - 7
ER -